Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BAT3221032: A Randomized, Controlled Study to Evaluate the Effects of Switching From Cigarette Smoking to Using One of Five Variants of a Heated Tobacco Product on Biomarkers of Exposure and Biomarkers of Potential Harm in Healthy Subjects

NCT05142436 is registered in ClinicalTrials.gov with British American Tobacco (Investments) Limited as lead sponsor.

NCT NCT05142436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05142436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BAT3221032: A Randomized, Controlled Study to Evaluate the Effects of Switching From Cigarette Smoking to Using One of Five Variants of a Heated Tobacco Product on Biomarkers of Exposure and Biomarkers of Potential Harm in Healthy Subjects
Lead sponsor
British American Tobacco (Investments) Limited
Phase
Not applicable
Overall status
Completed
Start date
January 13, 2022
Completion date
December 13, 2022
Enrollment
806 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

smoking, tobacco smoking, tobacco use